Search
for
Sort by
Research 271–300 of 1000+
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
- Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Hirsutism in the Adolescent Female
- Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- Phytochemicals in the Management of Polycystic Ovary Syndrome, Endometriosis, and Menstrual Irregularities
- Green Tea as a Supportive Therapy for PCOS: Evaluating Its Impact on Symptom Relief
- Correlation between Hormonal Imbalances and Adult Female Acne
- The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia
- Comparative evaluation of sonographic ovarian morphology of Indian women with polycystic ovary syndrome versus those of normal women
- Women’s Health Considerations for Lipid Management
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome
- Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
- Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- The association between serum ferritin and 25-hydroxyvitamin D and metabolic syndrome in Korean women: the Korea National Health and Nutrition Examination Survey 2010–2012
- Immunoglobulin E and Serum Interleukin-13 and Bacteria in Patients with Alopecia Areata
- Insulin resistance and metabolic syndrome in female androgenetic alopecia
- Insulin Resistance in Patients with Androgenic Alpoecia”
- Gender difference in relationship between serum ferritin and 25-hydroxyvitamin D in Korean adults
- Serum 1, 25-dihydroxy vitamin D- vitamin D3- among obese Egyptian women with polycystic ovary syndrome
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Relationship of Serum Prostate Specific Antigen with Hirsutism in Women Having Polycystic Ovary Syndrome Belonging to the Province of Khyber Pakhtunkhwa, Pakistan
- The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT